Wohl D, et al. Patient-reported outcomes among HIV-1-infected adults randomized to B/F/TAF versus DTG/ABC/3TC in two Phase 3 controlled clinical trials over 48 weeks. AIDS 2018.
CVST-VITT in lage-, midden- en hoge-inkomenslanden
sep 2023 | Neuro-vasculair, Vaccinatie, Virale infecties